Search hospitals > New Jersey > Livingston
Saint Barnabas Medical Center
Claim this profileLivingston, New Jersey 07039
Global Leader in Breast Cancer
Global Leader in Kidney Transplant
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Acute Lymphoblastic Leukemia
208 reported clinical trials
32 medical researchers
Summary
Saint Barnabas Medical Center is a medical facility located in Livingston, New Jersey. This center is recognized for care of Breast Cancer, Kidney Transplant, Breast cancer, Lung Cancer, Acute Lymphoblastic Leukemia and other specialties. Saint Barnabas Medical Center is involved with conducting 208 clinical trials across 337 conditions. There are 32 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Kidney Transplant
Global LeaderTop PIs
Howard S. HochsterRutgers Cancer Institute of New Jersey6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
37 drugs studied
Eugenia Girda, MDRutgers Cancer Institute of New Jersey5 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
16 reported clinical trials
31 drugs studied
Missak Haigentz, MDRutgers Cancer Institute of New Jersey4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
23 drugs studied
Mridula George, MDRutgers Cancer Institute of New Jersey2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
38 drugs studied
Clinical Trials running at Saint Barnabas Medical Center
Lung Cancer
Breast Cancer
Pancreatic Cancer
Prostate Cancer
Colon Cancer
Cancer
Ovarian Cancer
Breast cancer
Stroke
Acute Myeloid Leukemia
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Barnabas Medical Center?
Saint Barnabas Medical Center is a medical facility located in Livingston, New Jersey. This center is recognized for care of Breast Cancer, Kidney Transplant, Breast cancer, Lung Cancer, Acute Lymphoblastic Leukemia and other specialties. Saint Barnabas Medical Center is involved with conducting 208 clinical trials across 337 conditions. There are 32 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.